Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
Yuezhou Chen, Pei Tong, Noah B. Whiteman, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies
Monika Kumari, Ruei‐Min Lu, Mu‐Chun Li, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 111
Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity
Muriel Aguilar-Bretones, Ron A. M. Fouchier, Marion Koopmans, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 1
Open Access | Times Cited: 81
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
Iris Medits, David Niklas Springer, Marianne Graninger, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Véronique Barateau, Loïc Peyrot, Carla Saade, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 687
Open Access | Times Cited: 23
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 9
In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose
Paola Stolfi, Filippo Castiglione, Enrico Mastrostefano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Characterization of Vaccine-Enhanced Humoral Immune Responses Against Emergent SARS-CoV-2 Variants in a Convalescent Cohort
Jared Sheehan, Amber J. Trauth, Michael E. Hagensee, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 44-44
Open Access
In vivo determination of protective antibody thresholds for SARS-CoV-2 variants using mouse models
Peilan Wei, Ruoxi Cai, Lu Zhang, et al.
Emerging Microbes & Infections (2025)
Open Access
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 222
Open Access
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
Journal of Virology (2025)
Open Access
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatment
Jim Keijser, Eileen W Stalman, Luuk Wieske, et al.
EBioMedicine (2025) Vol. 113, pp. 105620-105620
Closed Access
Deep mutational learning for the selection of therapeutic antibodies resistant to the evolution of Omicron variants of SARS-CoV-2
Lester Frei, Beichen Gao, Jiami Han, et al.
Nature Biomedical Engineering (2025)
Open Access
Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection
Bette Liu, Heather F. Gidding, Sandrine Stepien, et al.
Vaccine (2022) Vol. 40, Iss. 43, pp. 6288-6294
Open Access | Times Cited: 24
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, et al.
Journal of Clinical Immunology (2023) Vol. 43, Iss. 7, pp. 1506-1518
Open Access | Times Cited: 13
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg‐Witte, et al.
EClinicalMedicine (2023) Vol. 61, pp. 102040-102040
Open Access | Times Cited: 12
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, et al.
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 67-73
Open Access | Times Cited: 18
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profiles
Emma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
iScience (2022) Vol. 26, Iss. 1, pp. 105862-105862
Open Access | Times Cited: 18
SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines
Thomas E. Hickey, Troy J. Kemp, Jimmie Bullock, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 10
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael Mallory, Patrick O. Byrne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure
Hyunhye Kang, Jin Jung, Geon Young Ko, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 301-301
Open Access | Times Cited: 3
Origins and diversity of pan-isotype human bone marrow plasma cells
Gaspar A. Pacheco, Vishal Rao, Duck Kyun Yoo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, et al.
Biochemical Society Transactions (2022) Vol. 50, Iss. 6, pp. 1643-1658
Open Access | Times Cited: 14
Immediate adverse reactions following COVID-19 vaccination among 16–65-year-old Danish citizens
KK Hansen, Fiona Kusk Povlsen, Bodil Hammer Bech, et al.
Vaccine (2023) Vol. 41, Iss. 33, pp. 4879-4887
Open Access | Times Cited: 8
Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection
Ruoke Wang, Yang Han, Rui Zhang, et al.
Immunity (2023) Vol. 56, Iss. 11, pp. 2635-2649.e6
Open Access | Times Cited: 8
Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines
Melissa García‐Vega, Hui Wan, Mónica Reséndiz‐Sandoval, et al.
Genes and Immunity (2024) Vol. 25, Iss. 2, pp. 158-167
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top